These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 17172917)
1. Misuse and abuse of topically applied nonsteroidal anti-inflammatory drugs. Flach AJ Cornea; 2006 Dec; 25(10):1265-6. PubMed ID: 17172917 [No Abstract] [Full Text] [Related]
2. Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug. Rho DS Cornea; 2006 Dec; 25(10):1266-7; author reply 1267-8. PubMed ID: 17172918 [No Abstract] [Full Text] [Related]
3. Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug. Asai T; Nakagami T; Mochizuki M; Hata N; Tsuchiya T; Hotta Y Cornea; 2006 Feb; 25(2):224-7. PubMed ID: 16371788 [TBL] [Abstract][Full Text] [Related]
4. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Lin JC; Rapuano CJ; Laibson PR; Eagle RC; Cohen EJ Arch Ophthalmol; 2000 Aug; 118(8):1129-32. PubMed ID: 10922213 [No Abstract] [Full Text] [Related]
6. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of bromfenac for the treatment of corneal ulcer pain. Schechter BA; Trattler W Adv Ther; 2010 Oct; 27(10):756-61. PubMed ID: 20845001 [TBL] [Abstract][Full Text] [Related]
8. Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug. Donnenfeld ED; Donnenfeld A Int Ophthalmol Clin; 2006; 46(4):21-40. PubMed ID: 17060789 [No Abstract] [Full Text] [Related]
9. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Flach AJ Trans Am Ophthalmol Soc; 2001; 99():205-10; discussion 210-2. PubMed ID: 11797308 [TBL] [Abstract][Full Text] [Related]
11. Topically applied nonsteroidal anti-inflammatory drugs and corneal problems: an interim review and comment. Flach A Ophthalmology; 2000 Jul; 107(7):1224-6. PubMed ID: 10889089 [No Abstract] [Full Text] [Related]
12. Corneal melting and perforation in Stevens Johnson syndrome following topical bromfenac use. Isawi H; Dhaliwal DK J Cataract Refract Surg; 2007 Sep; 33(9):1644-6. PubMed ID: 17720085 [TBL] [Abstract][Full Text] [Related]
13. Comparison of topically applied flurbiprofen or bromfenac ophthalmic solution on post-operative ocular hypertension in canine patients following cataract surgery. Lu J; English R; Nadelstein B; Weigt A; Berdoulay A; Binder D; Ngan E Vet Ophthalmol; 2017 Mar; 20(2):107-113. PubMed ID: 26990912 [TBL] [Abstract][Full Text] [Related]
14. Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent. Jones J; Francis P Expert Opin Pharmacother; 2009 Oct; 10(14):2379-85. PubMed ID: 19735215 [TBL] [Abstract][Full Text] [Related]
15. [One case of corneal melting after instillation of bromfenac 0.09%]. Troumani Y; Beral L; Glatre F; Finke E; David T J Fr Ophtalmol; 2014 Oct; 37(8):e125-7. PubMed ID: 24838029 [No Abstract] [Full Text] [Related]
16. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation. Donnenfeld ED; Holland EJ; Stewart RH; Gow JA; Grillone LR; Ophthalmology; 2007 Sep; 114(9):1653-62. PubMed ID: 17445902 [TBL] [Abstract][Full Text] [Related]